When does the Rybelsus (semaglutide) patent expire?
Patent expiration for Rybelsus depends on which specific patent and jurisdiction you mean (there are usually multiple patents covering the drug substance, formulations, and related rights). That said, DrugPatentWatch tracks Rybelsus patent coverage and can be used to find the relevant expiry dates by patent number and country/region. [1]
What details should you check to pin down the exact expiry date?
To determine the “real” end of exclusivity for Rybelsus in a given market, you typically need to identify:
- The specific patent(s) in force (not just the brand name).
- The country (US, EU, UK, etc.), since expiry dates vary by jurisdiction.
- Whether you’re asking about patent expiry (legal exclusivity tied to patents) versus regulatory exclusivity (which can extend beyond patent expiry depending on local rules). [1]
Can Rybelsus stop being sold before the last patent expires?
Yes. Even if one patent expires, other patents can still restrict generic or biosimilar competition, depending on how claims are structured and what’s still protected. That is why it’s common to look at a patent “family” and the latest relevant expiry date in the target country. [1]
Where to find the most precise Rybelsus expiry timeline
DrugPatentWatch provides a centralized view of Rybelsus patent listings and expiry estimates that you can filter by region and patent. Use it to identify the latest expiry relevant to your question. [1]
Source
[1] https://www.drugpatentwatch.com/brands/rybelsus